Back to search results

Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Treated With Tofacitinib and Statins vs TNF Inhibitors: TOFSTAT CLINICAL TRIAL

Abroad (travel likely)RecruitingPHASE4

Conditions

Rheumatoid Arthritis · Major Adverse Cardiac Events

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Shaikh Zayed Hospital, Lahore, Lahore, Punjab Province, Pakistan

    Contact: Study coordinator (Masooma Hashmat, FCPS) · masoomahashmat@gmail.com · +923353053304
    Contact: Study coordinator (Aflak Rasheed, FCPS) · aflakrasheed@yahoo.com · +923009476913
    Contact: Principal Investigator (Masooma Hashmat, FCPS)
    Contact: Principal Investigator (Aflak Rasheed, FCPS)
    Maira Khalil, MBBS (Sub-investigator)
Study leads

  • Masooma Hashmat, FCPS

    Principal Investigator

    Shaikh Zayed Hospital, Lahore

  • Aflak Rasheed, FCPS

    Study Director

    Shaikh Zayed Hospital, Lahore

  • Maira Khalil, MBBS

    Study Chair

    Shaikh Zayed Hospital, Lahore

View source on ClinicalTrials.gov(opens in a new tab)